monarcher: final os results of abemaciclib in hr , her breast cancer
Published 2 years ago • 196 plays • Length 1:57Download video MP4
Download video MP3
Similar videos
-
5:12
monarch 2: abemaciclib added to fulvestrant shows os benefit in hr /her2- advanced breast cancer
-
1:12
monarche: adjuvant abemaciclib in hr breast cancer
-
2:42
phase ii results for abemaciclib in pretreated hr /her2-negative breast cancer
-
1:39
abemaciclib for hr /her2- advanced or metastatic breast cancer
-
2:37
#esmo22 highlights on abemaciclib nsai in hr /her2- advanced breast cancer: the monarch 3 study
-
5:06
safety outcomes in the phase iii monarche trial of abemaciclib et in hr , her2- breast cancer
-
3:06
age-stratified findings from the monarche trial of abemaciclib in breast cancer
-
1:26
monarche: investigating adjuvant abemacicilib for high-risk hr breast cancer
-
1:13
significance of the monarch 2 findings for abemaciclib in hr /her2- breast cancer
-
1:48
natalee and monarche: ribociclib and abemaciclib in hr /her2- breast cancer
-
10:15
monaleesa-3 os results: fulvestrant/ribociclib in postmenopausal hr /her2- advanced breast cancer
-
1:08
4-year monarche results: increasing benefits with abemaciclib et for er /her2- high-risk early bc
-
4:19
abemaciclib plus nsai for hr , her2- advanced breast cancer - monarch 3 interim data
-
1:46
comment: monarch 3 trial: abemaciclib for advanced breast cancer
-
8:39
final overall survival analysis of monarch 1
-
0:53
postmonarche: abemaciclib fulvestrant in hr /her2- mbc following cdk4/6i & endocrine therapy
-
4:38
monarch 2: overall survival results from abermaciclib plus fulvestrant in hr her2- advanced bre...
-
2:10
monarche: adjuvant abemaciclib endocrine therapy in patients with hr , her2- high-risk ebc
-
6:07
hr breast cancer: updated results from monarch trials